Serial Number
88955869
Owner
TCG Digital Solutions, LLCAttorney
Andrew D. PriceFiling Date
Jun 9, 2020
TRIALXCH Trademark
Serial Number: 88955869 • Registration: 6325549
Trademark Classes
Owner Contact Info
265 Davidson Ave., Suite 220
Somerset, NJ 08873
Entity Type: 16
Legal Representation
Correspondence Address
Andrew D. Price VENABLE LLP
P.O. BOX 34385
WASHINGTON, DC 20043-9998
UNITED STATES
Trademark Details
Filing Date
June 9, 2020
Registration Date
April 20, 2021
Published for Opposition
February 2, 2021
Goods & Services
Providing temporary use of online, non-downloadable, internet-based software for use in clinical trials, namely, for providing information management and analytics services for identifying matching patients for participation in clinical trials, study design and associated analysis, using aggregated clinical data on patients from hospitals, and aggregating information on clinical trials inclusion/exclusion criteria from the public domain; Software as a Service (SaaS) featuring software for providing digital solutions in the nature of providing information management and analytics services for identifying matching patients for participation in clinical trials, study design and associated analysis, using aggregated clinical data on patients from hospitals, and aggregating information on clinical trials inclusion/exclusion criteria from the public domain, system optimization, performance management, and system support, all in the field of clinical trials; Providing temporary use of a web-based software application for identifying and matching patients for participation in clinical trials; Software as a service (SaaS) services featuring software for identifying and matching patients for participation in clinical trials; Providing temporary use of online, non-downloadable, internet-based software for use in aggregating clinical data from patients, hospitals, and medical professionals for use in clinical trials; Software as a Service (SaaS) featuring software for aggregating clinical data from patients, hospitals, and medical professionals for use in clinical trials